Results 221 to 230 of about 88,182,083 (298)

Joint associations of recovery capital and polygenic risk with electronic health record observed remission and relapse in substance use disorder: Longitudinal evidence from the All of Us research program

Addiction, EarlyView.
Abstract Background and aims Recovery capital and genetic liability may be related to substance use disorder (SUD) remission through psychosocial and biologic pathways, but their joint association with remission course remains poorly understood. This question is clinically important because people entering remission differ in recovery resources and ...
Janaka V. Kosgolla, Douglas C. Smith
wiley   +1 more source

Implementation of a Mobile Digital Tool Supporting Medication for Opioid Use Disorder Treatment Improves Retention: Stepped-Wedge Cluster Randomized Controlled Trial. [PDF]

J Med Internet Res
Palacios JE, Sherrick R, Janssen T, Deuble E, Lorenzen S, Schaefer M, Tregarthen J.   +6 more
europepmc   +1 more source

Clinicians' and people who use drugs' perspectives on artificial intelligence in addiction medicine

Addiction, EarlyView.
Abstract Background and aims Artificial intelligence (AI) may improve addiction medicine workflows and health outcomes but raises questions about data privacy and unintended harms for people who use drugs (PWUD). This qualitative study aimed to understand the perspectives of clinicians and PWUD regarding perceived benefits and concerns about clinical ...
Patrick J. A. Kelly, Elizabeth Chen, Amelia Bailey, Katie Biello, Brandon D. L. Marshall, Josiah D. Rich, Jaclyn M. W. Hughto   +6 more
wiley   +1 more source

Lived Experiences of Medication for Opioid Use Disorder: Clients' Perspectives on Formulation and Treatment. [PDF]

Subst Use
Kedia S, Schmidt M, Entwistle C, Ahuja N, Mahmood A, Dillon PJ.   +5 more
europepmc   +1 more source

A framework to determine naloxone saturation with simulation modeling and cost‐effectiveness methods

Addiction, EarlyView.
Abstract Background and aims Jurisdictions lack practical tools to determine data‐informed naloxone saturation targets that account for local overdose dynamics and resource constraints. We aimed to introduce a generalizable framework that integrates simulation modeling with cost‐effectiveness principles to identify local naloxone saturation targets ...
Zongbo Li, Leah C. Shaw, Carolyn J. Park, Alexander Y. Walley, Czarina N. Behrends, Bruce R. Schackman, Brandon D. L. Marshall, Xiao Zang   +7 more
wiley   +1 more source

A decade of cannabis‐related hospital admissions in Victoria, Australia: A retrospective observational study

Addiction, EarlyView.
Abstract Background and aims Over the past decade, there has been increased lifetime use of illicit and medical cannabis, underscoring the need to examine public health impacts. This includes reports of increased cannabis‐related psychosis. In this context, this study aimed to determine all cannabis‐related hospital admissions in Victoria, Australia ...
Myfanwy Graham, Janneke Berecki‐Gisolf, Jane Hayman, Adrian Carter, Shalini Arunogiri, Suzanne Nielsen   +5 more
wiley   +1 more source

Inpatient addiction care is associated with increased vaccinations, medication for opioid use disorder and naloxone prescribing among patients with infective endocarditis in a rural state. [PDF]

Addict Sci Clin Pract
Farkas EJ, Molina V, Mohoney B, Craig W, Schaumberg J, McAuliffe A, Thakarar K.   +6 more
europepmc   +1 more source

Accidental overdose admissions and premature death: A large population‐based data‐linkage cohort study in New South Wales, Australia (PAVLOVA 4)

Addiction, EarlyView.
Abstract Background and aims People with substance use disorders have reduced life‐expectancy; however, risks of premature death from injuries and natural causes following an accidental overdose are not well characterised. This study aimed to estimate risk of premature death (by cause and over time), and disease burden following hospitalised accidental
Firouzeh Noghrehchi, Rose Cairns, Darren M. Roberts, Kirsten C. Morley, Paul S. Haber, Nicholas A. Buckley   +5 more
wiley   +1 more source

The impact of the communities that HEAL intervention on the provision of jail-based medication for opioid use disorder & linkage programs at release: Results from a randomized, wait-list controlled trial. [PDF]

J Subst Use Addict Treat
Oser CB, Sprunger JG, Hunt T, Holloway J, Chandler RK, Freisthler B, Balvanz P, Henry BF, Glasgow L, Harris DR, Walsh SL, Aldridge AP, Asman K, Blevins D, Booty MD, Fox AD, Springer SA, Kinnard EN, Knott C, LeBaron PA, Levin FR, Marks KR, McGladrey ML, Nunes EV, Oga EA, Smith MR, Smith MS, Staton M, Stevens-Watkins D, Surratt HL, Walters ST, Zarkin GA, Friedmann PD.   +32 more
europepmc   +1 more source

Changes in the transition from cannabis use to use disorder by decade of first use: Findings from the Australian National Mental Health and Wellbeing surveys

Addiction, EarlyView.
Abstract Background and aims As cannabis becomes increasingly accessible and products more potent, it is critical that we understand how this may impact the risk of transitioning from cannabis use to cannabis use disorder (CUD). We aimed to examine whether the risk and speed of transition from cannabis use to CUD differ by decade of first cannabis use.
Jack Wilson, Siobhan O'Dean, Christina Marel, Olivia Dobson, Matthew Sunderland, Steph Kershaw, Tara Gückel, Emma Krogh Devine, Tim Slade, Maree Teesson, Emily Stockings   +10 more
wiley   +1 more source